频繁纵向微量采血与蛋白质组监测在1型糖尿病小鼠模型中识别疾病标志物并实现及时干预
本研究在成年NOD小鼠中每1-5天采集10μl全血制成干血斑,用邻位延伸分析监测蛋白质组,发现病毒感染后存在短暂分子变化,多层感知机分类器在感染后第2天预测感染状态准确率超过90%;在CVB3感染的SOCS-1转基因小鼠中,感染后第2天给予免疫血清可100%预防糖尿病,而对照有62.5%发病。
要点
- 频繁干血斑采样可捕捉常规低频采样遗漏的短暂蛋白质组变化。
- 多层感知机分类器在感染后第2天预测感染状态准确率超过90%。
- 感染后第2天免疫血清治疗使CVB3感染的SOCS-1转基因小鼠糖尿病发病率为0%。
核心结论
- 频繁采集的干血斑样本可用于监测1型糖尿病症状前阶段环境触发因素诱导的动态蛋白质组变化,从而实现疾病拦截。
研究设计与样本
- 研究对成年NOD小鼠每1-5天采集10μl全血,5μl滴于滤纸制成干血斑,用邻位延伸分析检测蛋白质组。
- 小鼠分别感染柯萨奇病毒B3(CVB3)或仅接受溶剂对照,使用广义相加模型评估蛋白质水平与感染后天数的线性和非线性关系。
- 开发多层感知机(MLP)分类器预测感染状态;CVB3感染的SOCS-1转基因小鼠在感染后第2天和第3天分别接受免疫血清或非免疫血清治疗并监测糖尿病发展。
主要发现
- 频繁采血和纵向蛋白质组监测揭示了病毒感染动物中短暂分子变化,低频采样会遗漏这些变化。
- MLP分类器在感染后第2天之后预测感染状态的准确率超过90%。
- 感染后第2天接受免疫血清治疗的CVB3感染SOCS-1转基因NOD小鼠全部(100%)未发生糖尿病。
- 接受非免疫血清治疗的CVB3感染对照中,8只中有5只(62.5%)发生糖尿病。
关键数值与推荐
- 全血采样体积为10μl,干血斑点样体积为5μl,采样频率为每1-5天一次。
- MLP分类器预测感染状态的准确率超过90%。
- 免疫血清治疗组糖尿病发病率为0%(100%未发病),非免疫血清对照组为62.5%(5/8)。
临床怎么用
- 定期自我采集干血斑结合蛋白质组监测,可在1型糖尿病症状前阶段检测环境触发因素引起的短暂分子变化。
- 基于蛋白质组数据的机器学习分类器有助于早期识别感染等触发事件。
- 在识别触发事件后及时给予免疫干预可能拦截1型糖尿病进展,该策略可转化至人类研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes manifests after irreversible beta cell damage, highlighting the crucial need for markers of the presymptomatic phase to enable early and effective interventions. Current efforts to identify molecular markers of disease-triggering events lack resolution and convenience. Analysing frequently self-collected dried blood spots (DBS) could enable the detection of early disease-predictive markers and facilitate tailored interventions. Here, we present a novel strategy for monitoring transient molecular changes induced by environmental triggers that enable timely disease interception. METHODS: Whole blood (10 μl) was sampled regularly (every 1-5 days) from adult NOD mice infected with Coxsackievirus B3 (CVB3) or treated with vehicle alone. Blood samples (5 μl) were dried on filter discs. DBS samples were analysed by proximity extension assay. Generalised additive models were used to assess linear and non-linear relationships between protein levels and the number of days post infection (p.i.). A multi-layer perceptron (MLP) classifier was developed to predict infection status. CVB3-infected SOCS-1-transgenic (tg) mice were treated with immune- or non-immune sera on days 2 and 3 p.i., followed by monitoring of diabetes development. RESULTS: Frequent blood sampling and longitudinal measurement of the blood proteome revealed transient molecular changes in virus-infected animals that would have been missed with less frequent sampling. The MLP classifier predicted infection status after day 2 p.i. with over 90% accuracy. Treatment with immune sera on day 2 p.i. prevented diabetes development in all (100%) of CVB3-infected SOCS-1-tg NOD mice while five out of eight (62.5%) of the CVB3-infected controls treated with non-immune sera developed diabetes. CONCLUSIONS/INTERPRETATION: Our study demonstrates the utility of frequently collected DBS samples to monitor dynamic proteome changes induced by an environmental trigger during the presymptomatic phase of type 1 diabetes. This approach enables disease interception and can be translated into human initiatives, offering a new method for early detection and intervention in type 1 diabetes. DATA AND CODE AVAILABILITY: Additional data available at https://doi.org/10.17044/scilifelab.27368322 . Additional visualisations are presented in the Shiny app interface https://mouse-dbs-profiling.serve.scilifelab.se/ .
引用
- Parajuli A, Bendes A, Byvald F, et al. Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes. Diabetologia. 2025. PMID: 40760251. doi:10.1007/s00125-025-06502-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。